| UHC UMR Medical and Drug | Vertebral Body Tethering for Scoliosis – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Category III Codes – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Denosumab – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Erythropoiesis-Stimulating Agents – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Evkeeza® (Evinacumab-Dgnb) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Gender Dysphoria Treatment – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Genetic Testing for Hereditary Cancer – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Home Traction Therapy – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Immune Globulin (IVIG and SCIG) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Leqembi® (Lecanemab-Irmb) – Commercial Medical Benefit Drug Policy | 2026-04-01 |